mc val cit pab — TargetMol Chemicals

Cat No.	Product Name	Synonyms	Targets
T18321	Mc-Val-Cit-PAB-Cl		Others
	Mc-Val-Cit-PAB-Cl, a cleavable ADC linker, is utilized in the conjugation of MMAE and antibodies to produce compounds such as antibody-MC-vc-MMAE (e.g., anti-CD22-MC-VC-PABC-MMAE), which demonstrate cytotoxicity with IC5...		Others
T5149	MC-Val-Cit-PAB		Others , AChR
	MC-Val-Cit-PAB is a cathepsin cleavable ADC linker that is used for making antibody-drug conjugate. FDA approved drugs such as brentuximab vedotin use this linker.		Others , AChR
T77847	MC-Val-Cit-PAB-Exatecan	MC-Val-Cit-PAB-DX8951
	MC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) is a conjugate of the DNA topoisomerase I inhibitor DX-8951 and a cathepsin-cleavable antibody-drug conjugate (ADC) linker, designed for targeted cancer therapy application...
T18320	MC-Val-Cit-PAB-carfilzomib iodide	MC-Val-Cit-PAB-carfilzomib	Others
	MC-Val-Cit-PAB-carfilzomib is a potent antitumor drug-linker conjugate for antibody-drug conjugates (ADC), comprising the irreversible proteasome inhibitor carfilzomib, connected through the ADC linker MC-Val-Cit-PAB.		Others
T18324	MC-Val-Cit-PAB-duocarmycin chloride	MC-Val-Cit-PAB-duocarmycin	Others
	MC-Val-Cit-PAB-duocarmycin is an antibody-drug conjugate (ADC) linker that combines duocarmycin, a potent DNA minor groove-binding alkylating agent, with an antitumor drug through the MC-Val-Cit-PAB linker, exhibiting si...		Others
T33243	MC-Val-Cit-PAB-VX765	Belnacasan-conjugate,VX765-conjugate,MC-Val-Cit-PABC-VX765
	MC-VAL-CIT-PAB-VX765 or MC-VAL-CIT-PABC-VX765 is a VX765 derivative that can be conjugated to antibodies, proteins, or polymers for targeted drug delivery. MC-Val- CIT -PAB is a cathepsin cleavable ADC connector, which h...
T18323	MC-Val-Cit-PAB-dimethylDNA31		Others
	MC-Val-Cit-PAB-dimethylDNA31 is a drug-linker conjugate employed in antibody-drug conjugates (ADCs) that exhibits robust antitumor efficacy. This conjugate utilizes the ADC linker, MC-Val-Cit-PAB, to link to the potent a...		Others
T18330	MC-Val-Cit-PAB-vinblastine		Others
	MC-Val-Cit-PAB-vinblastine is a potent antitumor drug-linker conjugate for Antibody-Drug Conjugates (ADC), featuring vinblastine (a microtubule protein inhibitor) connected through the MC-Val-Cit-PAB ADC linker.		Others
T18327	MC-Val-Cit-PAB-Retapamulin		Others
	MC-Val-Cit-PAB-Retapamulin is a drug-linker conjugate for antibody-drug conjugates (ADC) that exhibits potent antitumor activity. This compound utilizes Retapamulin, a ribosome inhibitor, connected through the ADC linker...		Others
T18326	MC-Val-Cit-PAB-MMAF		Others
	MC-Val-Cit-PAB-MMAF is an antibody-drug conjugate (ADC) component that exhibits antitumor properties through the action of the tubulin inhibitor, monomethyl auristatin F (MMAF), which is connected by a cathepsin-cleavabl...		Others
T18325	MC-Val-Cit-PAB-Indibulin		Others
	MC-Val-Cit-PAB-Indibulin is an antitumor drug-linker conjugate for antibody-drug conjugates (ADCs), featuring the orally active tubulin assembly inhibitor, Indibulin, connected through the MC-Val-Cit-PAB ADC linker. This...		Others
T18328	MC-Val-Cit-PAB-rifabutin		Others
	MC-Val-Cit-PAB-rifabutin is a drug-linker conjugate designed for antibody-drug conjugates (ADC), featuring the potent antitumor agent rifabutin (a DNA-dependent RNA polymerase inhibitor) connected through the MC-Val-Cit-...		Others
T18322	MC-Val-Cit-PAB-clindamycin		Others
	MC-Val-Cit-PAB-clindamycin is an antibody-drug conjugate (ADC) linker that combines the potent antitumor properties of clindamycin, a protein synthesis inhibitor, with the ADC linker MC-Val-Cit-PAB, to enhance its abilit...		Others
T18319	MC-Val-Cit-PAB-Auristatin E		Others
	MC-Val-Cit-PAB-Auristatin E is an antibody-drug conjugate (ADC) linker compound featuring Auristatin E, a potent cytotoxic tubulin modifier, connected through the MC-Val-Cit-PAB linker, exhibiting significant antitumor a...		Others
T31567	Doxorubicin-MVCP	MC-Val-Cit-PAB-Doxorubicin,MC-Val-Cit-PAB-Dox
	Doxorubicin-MVCP (MC-Val-Cit-PAB-Doxorubicin) is a Doxorubicin derivative with an MC-Val-Cit-PAB linker.
T18329	MC-VC(S)-PABQ-Tubulysin M	MC-Val-Cit-PAB-tubulysin5a	Others
	MC-Val-Cit-PAB-tubulysin5a is a drug-linker conjugate for ADC with potent antitumor activity by using tubulysin5a (a tubulin inhibitor), linked via the ADC linker MC-Val-Cit-PAB.		Others
T77875	Mc-Val-Cit-PAB-Gefitinib chloride
	Mc-Val-Cit-PAB-Gefitinib chloride is a conjugate agent-linker for antibody-drug conjugates (ADCs) that combines Gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, with the proprietary ADC li...
T77826	MC-Val-Cit-PAB-NH-C2-NH-Boc
	MC-Val-Cit-PAB-NH-C2-NH-Boc is a cathepsin-cleavable ADC linker utilized in constructing antibody-drug conjugates (ADCs) [1].
T74468	MC-Val-Cit-PAB-Amide-TLR7 agonist 4
	MC-Val-Cit-PAB-Amide-TLR7 agonist 4 (example 15) is a conjugate that acts as an immune agonist targeting both HER2-TLR7 and HER2-TLR8 pathways [1].
T33861	Paclitaxel-MVCP
	Paclitaxel-MVCP ( MC-val-cit-pab-paclitaxel )is a paclitaxel derivative with an MC-Val-Cit-PAB linker, which can be used for the preparation of Paclitaxel conjugates for drug delivery and nanomedicine research.